——A First-in-Class Hydrolysis-Activated Liver-Targeted THR-β Prodrug Demonstrating A Dual Advantage of Fat Reduction and Muscle Preservation SHANGHAI, May 16, 2025 /PRNewswire/ -- At the European ...
——A First-in-Class Hydrolysis-Activated Liver-Targeted THR-ß Prodrug Demonstrating A Dual Advantage of Fat Reduction and Muscle Preservation While GLP-1 receptor agonists (e.g., semaglutide, ...
While GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) face challenges in sustained weight control and muscle preservation, CG-0416 employs precision targeting of complementary metabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback